Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Health Behavior | 30 | 2023 | 2650 | 4.920 |
Why?
|
Acute Coronary Syndrome | 19 | 2021 | 2194 | 3.660 |
Why?
|
Depression | 37 | 2023 | 8230 | 3.190 |
Why?
|
Heart Diseases | 17 | 2020 | 2819 | 2.650 |
Why?
|
Patient Compliance | 11 | 2020 | 2697 | 2.200 |
Why?
|
Anxiety Disorders | 16 | 2021 | 2748 | 2.140 |
Why?
|
Psychotherapy | 11 | 2020 | 1654 | 2.130 |
Why?
|
Hematopoietic Stem Cell Transplantation | 15 | 2024 | 5717 | 2.050 |
Why?
|
Psychiatry | 10 | 2022 | 1716 | 1.930 |
Why?
|
Health Promotion | 14 | 2023 | 2210 | 1.870 |
Why?
|
Anxiety | 16 | 2024 | 4672 | 1.780 |
Why?
|
Exercise | 20 | 2022 | 5955 | 1.510 |
Why?
|
Hematologic Neoplasms | 8 | 2024 | 1907 | 1.360 |
Why?
|
Quality of Life | 22 | 2024 | 13490 | 1.320 |
Why?
|
Depressive Disorder | 10 | 2018 | 3721 | 1.280 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2023 | 12252 | 1.260 |
Why?
|
Suicidal Ideation | 11 | 2022 | 1462 | 1.230 |
Why?
|
Cardiovascular Diseases | 18 | 2024 | 15662 | 1.220 |
Why?
|
Inpatients | 12 | 2022 | 2566 | 1.210 |
Why?
|
Depressive Disorder, Major | 14 | 2023 | 4818 | 1.160 |
Why?
|
Behavior Therapy | 5 | 2021 | 886 | 1.140 |
Why?
|
Chest Pain | 5 | 2022 | 1101 | 1.120 |
Why?
|
Antidepressive Agents | 12 | 2020 | 2913 | 1.120 |
Why?
|
Feasibility Studies | 18 | 2024 | 5315 | 1.120 |
Why?
|
Psychosomatic Medicine | 5 | 2015 | 72 | 1.090 |
Why?
|
Mental Disorders | 11 | 2021 | 6874 | 1.080 |
Why?
|
Cooperative Behavior | 7 | 2017 | 1514 | 1.070 |
Why?
|
Bariatric Surgery | 4 | 2021 | 1001 | 1.070 |
Why?
|
Panic Disorder | 5 | 2016 | 613 | 1.060 |
Why?
|
Antipsychotic Agents | 11 | 2022 | 3081 | 1.050 |
Why?
|
Long QT Syndrome | 3 | 2017 | 472 | 1.050 |
Why?
|
Heart Failure | 13 | 2023 | 11879 | 1.040 |
Why?
|
Anti-Anxiety Agents | 5 | 2013 | 405 | 0.990 |
Why?
|
Emotions | 6 | 2021 | 2767 | 0.980 |
Why?
|
Torsades de Pointes | 2 | 2017 | 78 | 0.930 |
Why?
|
Psychomotor Agitation | 3 | 2016 | 307 | 0.900 |
Why?
|
Patient Simulation | 2 | 2016 | 297 | 0.900 |
Why?
|
Pilot Projects | 17 | 2024 | 8741 | 0.890 |
Why?
|
Humans | 182 | 2024 | 768166 | 0.860 |
Why?
|
Psychotherapy, Group | 4 | 2019 | 417 | 0.860 |
Why?
|
Stress, Psychological | 8 | 2024 | 4530 | 0.830 |
Why?
|
Renal Insufficiency | 3 | 2023 | 812 | 0.800 |
Why?
|
Personal Satisfaction | 3 | 2019 | 643 | 0.790 |
Why?
|
Coronary Artery Disease | 7 | 2020 | 6568 | 0.780 |
Why?
|
Affect | 2 | 2019 | 1495 | 0.740 |
Why?
|
Happiness | 3 | 2019 | 170 | 0.730 |
Why?
|
Patient Care Team | 7 | 2016 | 2523 | 0.710 |
Why?
|
Delirium | 5 | 2022 | 1697 | 0.690 |
Why?
|
Telemedicine | 5 | 2021 | 3109 | 0.680 |
Why?
|
Middle Aged | 71 | 2024 | 223492 | 0.660 |
Why?
|
Attitude to Health | 3 | 2015 | 2025 | 0.660 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2017 | 951 | 0.630 |
Why?
|
Attitude | 2 | 2013 | 771 | 0.590 |
Why?
|
Mental Health Services | 3 | 2020 | 1732 | 0.580 |
Why?
|
Bipolar Disorder | 5 | 2018 | 5130 | 0.570 |
Why?
|
Psychiatric Status Rating Scales | 6 | 2018 | 6029 | 0.560 |
Why?
|
Male | 80 | 2024 | 364719 | 0.550 |
Why?
|
Telephone | 4 | 2022 | 630 | 0.540 |
Why?
|
Arrhythmias, Cardiac | 6 | 2014 | 2258 | 0.540 |
Why?
|
Female | 83 | 2024 | 397192 | 0.530 |
Why?
|
Myocardial Infarction | 7 | 2013 | 11519 | 0.510 |
Why?
|
Self Care | 2 | 2018 | 799 | 0.500 |
Why?
|
Clinical Competence | 4 | 2016 | 4858 | 0.490 |
Why?
|
Aged | 46 | 2024 | 171504 | 0.480 |
Why?
|
Outpatients | 2 | 2022 | 1600 | 0.470 |
Why?
|
Cardiovascular Agents | 3 | 2011 | 849 | 0.460 |
Why?
|
Internship and Residency | 5 | 2016 | 5953 | 0.460 |
Why?
|
Motor Activity | 2 | 2015 | 2711 | 0.460 |
Why?
|
Mental Health | 8 | 2022 | 3275 | 0.460 |
Why?
|
Qualitative Research | 7 | 2020 | 3140 | 0.450 |
Why?
|
Research Subjects | 1 | 2016 | 249 | 0.450 |
Why?
|
Motivation | 3 | 2020 | 2020 | 0.430 |
Why?
|
Neurology | 1 | 2021 | 786 | 0.420 |
Why?
|
Primary Health Care | 7 | 2021 | 4746 | 0.420 |
Why?
|
Chronic Disease | 6 | 2023 | 9384 | 0.410 |
Why?
|
Psychotropic Drugs | 2 | 2017 | 881 | 0.400 |
Why?
|
Program Development | 2 | 2016 | 1300 | 0.400 |
Why?
|
Interleukin-1 | 1 | 2016 | 1252 | 0.390 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2014 | 430 | 0.390 |
Why?
|
Obesity, Morbid | 2 | 2021 | 1298 | 0.390 |
Why?
|
Leukemia | 1 | 2020 | 1519 | 0.390 |
Why?
|
Comorbidity | 7 | 2022 | 10590 | 0.390 |
Why?
|
Catatonia | 3 | 2017 | 181 | 0.380 |
Why?
|
Weight Loss | 2 | 2020 | 2721 | 0.380 |
Why?
|
Suicide | 5 | 2022 | 1606 | 0.370 |
Why?
|
Teaching | 2 | 2016 | 1171 | 0.370 |
Why?
|
Naturopathy | 1 | 2010 | 13 | 0.370 |
Why?
|
Editorial Policies | 1 | 2015 | 458 | 0.360 |
Why?
|
Models, Psychological | 1 | 2015 | 825 | 0.360 |
Why?
|
Referral and Consultation | 4 | 2016 | 3620 | 0.360 |
Why?
|
Adult | 45 | 2024 | 223646 | 0.360 |
Why?
|
Patient Acceptance of Health Care | 3 | 2019 | 3231 | 0.350 |
Why?
|
Patient Readmission | 2 | 2015 | 3288 | 0.350 |
Why?
|
Borderline Personality Disorder | 3 | 2018 | 767 | 0.350 |
Why?
|
Health Facilities | 1 | 2015 | 578 | 0.350 |
Why?
|
Myelodysplastic Syndromes | 1 | 2020 | 1399 | 0.340 |
Why?
|
Suicide, Attempted | 4 | 2022 | 1409 | 0.340 |
Why?
|
Coronary Stenosis | 1 | 2016 | 802 | 0.340 |
Why?
|
Single-Blind Method | 4 | 2016 | 1587 | 0.340 |
Why?
|
Personality Inventory | 2 | 2010 | 1018 | 0.340 |
Why?
|
C-Reactive Protein | 3 | 2022 | 3858 | 0.320 |
Why?
|
Ambulatory Care | 1 | 2020 | 2783 | 0.320 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2024 | 4640 | 0.320 |
Why?
|
Peer Group | 2 | 2024 | 700 | 0.320 |
Why?
|
Hydrocortisone | 1 | 2016 | 1841 | 0.290 |
Why?
|
Citalopram | 2 | 2017 | 401 | 0.290 |
Why?
|
Irritable Bowel Syndrome | 2 | 2023 | 454 | 0.280 |
Why?
|
Hospitalization | 7 | 2022 | 10840 | 0.280 |
Why?
|
Obesity | 2 | 2020 | 13090 | 0.280 |
Why?
|
Self-Assessment | 2 | 2021 | 400 | 0.260 |
Why?
|
Medication Adherence | 3 | 2022 | 2187 | 0.260 |
Why?
|
Survivors | 4 | 2024 | 2381 | 0.260 |
Why?
|
Electroconvulsive Therapy | 2 | 2008 | 505 | 0.260 |
Why?
|
Interleukin-6 | 1 | 2016 | 3228 | 0.250 |
Why?
|
Attitude of Health Personnel | 2 | 2013 | 3929 | 0.250 |
Why?
|
Gastrointestinal Diseases | 1 | 2013 | 1206 | 0.240 |
Why?
|
Empathy | 2 | 2019 | 474 | 0.240 |
Why?
|
Lorazepam | 1 | 2005 | 155 | 0.240 |
Why?
|
Periodicals as Topic | 1 | 2015 | 1465 | 0.230 |
Why?
|
Benzodiazepines | 2 | 2016 | 1138 | 0.230 |
Why?
|
Treatment Outcome | 16 | 2022 | 65371 | 0.230 |
Why?
|
Mood Disorders | 3 | 2018 | 1129 | 0.230 |
Why?
|
Follow-Up Studies | 11 | 2017 | 39348 | 0.230 |
Why?
|
Hyperparathyroidism | 1 | 2005 | 339 | 0.220 |
Why?
|
Rage | 1 | 2003 | 29 | 0.220 |
Why?
|
Munchausen Syndrome | 1 | 2003 | 19 | 0.220 |
Why?
|
Prospective Studies | 14 | 2023 | 54926 | 0.220 |
Why?
|
Educational Measurement | 1 | 2010 | 1260 | 0.220 |
Why?
|
Psychopharmacology | 1 | 2005 | 146 | 0.220 |
Why?
|
Self Concept | 2 | 2019 | 1043 | 0.220 |
Why?
|
Treatment Refusal | 2 | 2003 | 433 | 0.210 |
Why?
|
Anti-Infective Agents | 1 | 2011 | 983 | 0.210 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2019 | 4055 | 0.210 |
Why?
|
Antihypertensive Agents | 2 | 2011 | 2029 | 0.210 |
Why?
|
Nurse-Patient Relations | 1 | 2003 | 101 | 0.210 |
Why?
|
Health Care Costs | 1 | 2016 | 3239 | 0.200 |
Why?
|
Risk Factors | 16 | 2023 | 74944 | 0.200 |
Why?
|
Acetaminophen | 2 | 2003 | 552 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.200 |
Why?
|
Hypercalcemia | 1 | 2005 | 424 | 0.200 |
Why?
|
Hepatic Encephalopathy | 1 | 2003 | 144 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.200 |
Why?
|
Diagnosis, Differential | 8 | 2016 | 13014 | 0.200 |
Why?
|
Social Support | 5 | 2024 | 2193 | 0.200 |
Why?
|
Quinolones | 1 | 2005 | 389 | 0.200 |
Why?
|
Schizophrenia | 3 | 2010 | 6983 | 0.200 |
Why?
|
Drug Therapy, Combination | 2 | 2011 | 6316 | 0.190 |
Why?
|
Restraint, Physical | 1 | 2003 | 185 | 0.190 |
Why?
|
Heart Failure, Systolic | 1 | 2023 | 134 | 0.190 |
Why?
|
Myocardial Ischemia | 3 | 2017 | 2138 | 0.190 |
Why?
|
Pandemics | 2 | 2021 | 8748 | 0.180 |
Why?
|
Brugada Syndrome | 1 | 2022 | 98 | 0.180 |
Why?
|
Waiting Lists | 2 | 2016 | 779 | 0.180 |
Why?
|
Cholesterol | 1 | 2010 | 2914 | 0.180 |
Why?
|
Migraine Disorders | 1 | 2013 | 1713 | 0.180 |
Why?
|
Acute Disease | 4 | 2016 | 7243 | 0.180 |
Why?
|
Interdisciplinary Communication | 2 | 2016 | 937 | 0.170 |
Why?
|
Intensive Care Units | 1 | 2013 | 3800 | 0.170 |
Why?
|
Severity of Illness Index | 6 | 2012 | 15948 | 0.170 |
Why?
|
Anticonvulsants | 2 | 2022 | 1923 | 0.170 |
Why?
|
Guilt | 1 | 2020 | 93 | 0.170 |
Why?
|
Interviews as Topic | 2 | 2020 | 2741 | 0.170 |
Why?
|
Psychometrics | 4 | 2022 | 3063 | 0.170 |
Why?
|
Self Efficacy | 2 | 2022 | 643 | 0.160 |
Why?
|
Regression Analysis | 3 | 2016 | 6340 | 0.160 |
Why?
|
Mass Screening | 3 | 2010 | 5458 | 0.160 |
Why?
|
Caregivers | 2 | 2024 | 2302 | 0.160 |
Why?
|
Neurotransmitter Agents | 1 | 2022 | 663 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2024 | 10399 | 0.150 |
Why?
|
Thiophenes | 1 | 2003 | 570 | 0.150 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2008 | 1250 | 0.150 |
Why?
|
Diabetes Mellitus | 2 | 2013 | 5889 | 0.150 |
Why?
|
Diet | 4 | 2022 | 8089 | 0.150 |
Why?
|
Adaptation, Psychological | 3 | 2018 | 2663 | 0.150 |
Why?
|
Meditation | 1 | 2021 | 257 | 0.150 |
Why?
|
Curriculum | 2 | 2016 | 3782 | 0.140 |
Why?
|
Iran | 1 | 2020 | 763 | 0.140 |
Why?
|
Individuality | 1 | 2019 | 307 | 0.140 |
Why?
|
Aged, 80 and over | 10 | 2023 | 59629 | 0.140 |
Why?
|
Computer Systems | 1 | 2018 | 469 | 0.140 |
Why?
|
Inflammation | 1 | 2017 | 10873 | 0.140 |
Why?
|
Actigraphy | 1 | 2021 | 527 | 0.140 |
Why?
|
Coronary Artery Bypass | 2 | 2016 | 2191 | 0.140 |
Why?
|
Relaxation Therapy | 1 | 2018 | 181 | 0.140 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2005 | 2204 | 0.140 |
Why?
|
Therapy, Computer-Assisted | 1 | 2018 | 265 | 0.130 |
Why?
|
Loneliness | 1 | 2018 | 211 | 0.130 |
Why?
|
Spouses | 1 | 2018 | 286 | 0.130 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 26379 | 0.130 |
Why?
|
Health Personnel | 1 | 2010 | 3385 | 0.130 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2018 | 263 | 0.130 |
Why?
|
Vitamin D Deficiency | 1 | 2005 | 1388 | 0.130 |
Why?
|
Endothelin-1 | 1 | 2017 | 296 | 0.120 |
Why?
|
Health Status | 3 | 2016 | 4091 | 0.120 |
Why?
|
Transplantation, Homologous | 1 | 2024 | 4833 | 0.120 |
Why?
|
Monitoring, Ambulatory | 1 | 2018 | 358 | 0.120 |
Why?
|
Body Image | 1 | 2020 | 646 | 0.120 |
Why?
|
Piperazines | 1 | 2005 | 2554 | 0.120 |
Why?
|
Databases, Bibliographic | 1 | 2015 | 128 | 0.120 |
Why?
|
Feedback | 1 | 2018 | 799 | 0.120 |
Why?
|
Risk Assessment | 5 | 2022 | 24315 | 0.120 |
Why?
|
Asthma | 1 | 2013 | 6291 | 0.120 |
Why?
|
Young Adult | 8 | 2022 | 60066 | 0.120 |
Why?
|
Altruism | 1 | 2016 | 211 | 0.110 |
Why?
|
Sickness Impact Profile | 1 | 2015 | 299 | 0.110 |
Why?
|
Risk | 2 | 2016 | 9613 | 0.110 |
Why?
|
Habits | 1 | 2014 | 148 | 0.110 |
Why?
|
Physician-Patient Relations | 2 | 2003 | 3269 | 0.110 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2017 | 1134 | 0.110 |
Why?
|
Patient Discharge | 3 | 2021 | 3479 | 0.110 |
Why?
|
Publications | 1 | 2015 | 195 | 0.100 |
Why?
|
Likelihood Functions | 1 | 2016 | 994 | 0.100 |
Why?
|
Pituitary-Adrenal System | 1 | 2016 | 555 | 0.100 |
Why?
|
Primary Prevention | 1 | 2019 | 1188 | 0.100 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 903 | 0.100 |
Why?
|
Social Work | 1 | 2013 | 158 | 0.100 |
Why?
|
Reference Values | 1 | 2019 | 4938 | 0.100 |
Why?
|
Emergency Service, Hospital | 3 | 2022 | 7951 | 0.100 |
Why?
|
Models, Economic | 1 | 2016 | 719 | 0.100 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2016 | 702 | 0.100 |
Why?
|
Hypertension | 2 | 2018 | 8616 | 0.100 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2784 | 0.090 |
Why?
|
Liver Transplantation | 1 | 2003 | 2401 | 0.090 |
Why?
|
Academies and Institutes | 1 | 2013 | 326 | 0.090 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2011 | 91 | 0.090 |
Why?
|
Social Work, Psychiatric | 1 | 2011 | 21 | 0.090 |
Why?
|
Interpersonal Relations | 1 | 2018 | 1434 | 0.090 |
Why?
|
Fear | 1 | 2020 | 1495 | 0.090 |
Why?
|
Saliva | 1 | 2016 | 853 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2019 | 14783 | 0.090 |
Why?
|
Odds Ratio | 2 | 2013 | 9669 | 0.090 |
Why?
|
Electrocardiography | 3 | 2022 | 6412 | 0.090 |
Why?
|
Self Report | 3 | 2017 | 3773 | 0.090 |
Why?
|
Time Factors | 5 | 2021 | 40218 | 0.090 |
Why?
|
Education, Medical, Graduate | 2 | 2015 | 2420 | 0.090 |
Why?
|
Interleukin-17 | 1 | 2017 | 924 | 0.090 |
Why?
|
Research Design | 3 | 2021 | 6211 | 0.090 |
Why?
|
Cost Savings | 1 | 2016 | 904 | 0.090 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 350 | 0.090 |
Why?
|
Psychotic Disorders | 1 | 2005 | 3276 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2007 | 1243 | 0.080 |
Why?
|
Medical Audit | 1 | 2011 | 454 | 0.080 |
Why?
|
Hospitals, Psychiatric | 1 | 2011 | 317 | 0.080 |
Why?
|
Health Resources | 1 | 2016 | 950 | 0.080 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 3049 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12077 | 0.080 |
Why?
|
Multifactorial Inheritance | 1 | 2017 | 1422 | 0.080 |
Why?
|
Quality-Adjusted Life Years | 1 | 2016 | 1741 | 0.080 |
Why?
|
Prognosis | 4 | 2021 | 30010 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1397 | 0.080 |
Why?
|
Personality | 1 | 2012 | 559 | 0.080 |
Why?
|
Coronary Care Units | 1 | 2010 | 235 | 0.080 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2017 | 1751 | 0.080 |
Why?
|
Leukocyte Count | 1 | 2012 | 1609 | 0.070 |
Why?
|
Prevalence | 3 | 2022 | 15869 | 0.070 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13676 | 0.070 |
Why?
|
Coronary Disease | 1 | 2022 | 5919 | 0.070 |
Why?
|
Fatigue | 2 | 2020 | 1557 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2013 | 15454 | 0.070 |
Why?
|
Problem-Based Learning | 1 | 2010 | 360 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3436 | 0.070 |
Why?
|
Heart Block | 1 | 2008 | 390 | 0.070 |
Why?
|
Cognition | 1 | 2004 | 7073 | 0.070 |
Why?
|
Diagnostic Tests, Routine | 1 | 2012 | 789 | 0.070 |
Why?
|
Recurrence | 2 | 2008 | 8509 | 0.060 |
Why?
|
Drug Utilization | 1 | 2011 | 1189 | 0.060 |
Why?
|
Community Mental Health Services | 1 | 2008 | 388 | 0.060 |
Why?
|
Treatment Failure | 1 | 2011 | 2661 | 0.060 |
Why?
|
Mortality | 1 | 2016 | 2911 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5176 | 0.060 |
Why?
|
Atenolol | 1 | 2005 | 99 | 0.060 |
Why?
|
Algorithms | 2 | 2021 | 14164 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2017 | 5151 | 0.060 |
Why?
|
Encephalitis | 1 | 2008 | 441 | 0.060 |
Why?
|
Awareness | 1 | 2008 | 654 | 0.060 |
Why?
|
Specialization | 1 | 2009 | 779 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2015 | 4541 | 0.050 |
Why?
|
Reinforcement Schedule | 1 | 2003 | 123 | 0.050 |
Why?
|
Sick Role | 1 | 2003 | 229 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5536 | 0.050 |
Why?
|
Survival Analysis | 1 | 2015 | 10101 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6526 | 0.050 |
Why?
|
Catecholamines | 1 | 2003 | 389 | 0.050 |
Why?
|
Acetylcholinesterase | 1 | 2022 | 151 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3327 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 2019 | 4423 | 0.050 |
Why?
|
Blood Pressure | 1 | 2018 | 8543 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9419 | 0.050 |
Why?
|
Acetylcysteine | 1 | 2003 | 262 | 0.050 |
Why?
|
Length of Stay | 2 | 2017 | 6498 | 0.050 |
Why?
|
Internal-External Control | 1 | 2003 | 348 | 0.050 |
Why?
|
Benchmarking | 1 | 2008 | 1057 | 0.050 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2008 | 1988 | 0.050 |
Why?
|
Personality Assessment | 1 | 2003 | 646 | 0.050 |
Why?
|
Cohort Studies | 4 | 2022 | 41754 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2011 | 7454 | 0.050 |
Why?
|
Inservice Training | 1 | 2003 | 375 | 0.050 |
Why?
|
Haloperidol | 1 | 2022 | 394 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2337 | 0.040 |
Why?
|
Stroke | 1 | 2003 | 9755 | 0.040 |
Why?
|
Adolescent | 5 | 2022 | 89169 | 0.040 |
Why?
|
Risperidone | 1 | 2022 | 383 | 0.040 |
Why?
|
Aging | 1 | 2019 | 8744 | 0.040 |
Why?
|
Boston | 1 | 2013 | 9374 | 0.040 |
Why?
|
Students, Medical | 1 | 2013 | 1964 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2003 | 421 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2024 | 707 | 0.040 |
Why?
|
Social Perception | 1 | 2003 | 434 | 0.040 |
Why?
|
Mentors | 1 | 2005 | 671 | 0.040 |
Why?
|
Progesterone | 1 | 2024 | 752 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2010 | 2235 | 0.040 |
Why?
|
Interprofessional Relations | 1 | 2005 | 997 | 0.040 |
Why?
|
Heart Rate | 2 | 2021 | 4214 | 0.040 |
Why?
|
Logistic Models | 1 | 2013 | 13290 | 0.040 |
Why?
|
Health Services | 1 | 2003 | 755 | 0.040 |
Why?
|
Relaxation | 1 | 2018 | 51 | 0.040 |
Why?
|
Psychiatric Department, Hospital | 1 | 2018 | 133 | 0.040 |
Why?
|
Occupational Health Services | 1 | 2018 | 149 | 0.040 |
Why?
|
Cardiology | 1 | 2008 | 1702 | 0.040 |
Why?
|
United States | 4 | 2022 | 73039 | 0.030 |
Why?
|
Self-Injurious Behavior | 1 | 2003 | 568 | 0.030 |
Why?
|
Patients | 1 | 2023 | 908 | 0.030 |
Why?
|
Massachusetts | 1 | 2010 | 8890 | 0.030 |
Why?
|
Estradiol | 1 | 2024 | 1951 | 0.030 |
Why?
|
Analgesics | 1 | 2003 | 1071 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2003 | 841 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8542 | 0.030 |
Why?
|
Brain | 1 | 2022 | 27360 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 18065 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 916 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4598 | 0.030 |
Why?
|
Smoking | 1 | 2012 | 9092 | 0.030 |
Why?
|
Disease Progression | 1 | 2012 | 13671 | 0.030 |
Why?
|
Death, Sudden, Cardiac | 1 | 2022 | 1567 | 0.030 |
Why?
|
Group Processes | 1 | 2015 | 227 | 0.030 |
Why?
|
Social Environment | 1 | 2018 | 1012 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2011 | 22291 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22371 | 0.030 |
Why?
|
Gender Identity | 1 | 2018 | 770 | 0.030 |
Why?
|
Social Behavior | 1 | 2018 | 1147 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2024 | 3488 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3251 | 0.020 |
Why?
|
Incidence | 1 | 2010 | 21538 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 3729 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14729 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2022 | 2085 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3436 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2005 | 4573 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1752 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3886 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2008 | 315 | 0.020 |
Why?
|
Cost of Illness | 1 | 2017 | 1951 | 0.020 |
Why?
|
Lymphocytosis | 1 | 2008 | 121 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2003 | 8054 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 2008 | 540 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7852 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2008 | 914 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2008 | 20760 | 0.010 |
Why?
|
Animals | 1 | 2015 | 169246 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9538 | 0.010 |
Why?
|
Drug Resistance | 1 | 2008 | 1599 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2003 | 15832 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16726 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20227 | 0.010 |
Why?
|
Videotape Recording | 1 | 1998 | 335 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 81762 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18412 | 0.010 |
Why?
|
Interview, Psychological | 1 | 1998 | 810 | 0.010 |
Why?
|
Angiography | 1 | 1998 | 1597 | 0.010 |
Why?
|
Electroencephalography | 1 | 2008 | 6314 | 0.010 |
Why?
|